Please note that the copy function is not enabled for this field.
If you wish to
modify
existing outcomes, please copy and paste the current outcome text into the Update field.
LOGIN
CREATE ACCOUNT
LOGIN
CREATE ACCOUNT
MY TRIALS
REGISTER TRIAL
FAQs
HINTS AND TIPS
DEFINITIONS
Trial Review
The ANZCTR website will be unavailable from 1pm until 3pm (AEDT) on Wednesday the 30th of October for website maintenance. Please be sure to log out of the system in order to avoid any loss of data.
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this
information for consumers
Download to PDF
Trial registered on ANZCTR
Registration number
ACTRN12615000507583
Ethics application status
Approved
Date submitted
28/10/2014
Date registered
20/05/2015
Date last updated
20/05/2015
Type of registration
Retrospectively registered
Titles & IDs
Public title
Effects of oligofructose and inulin in management of chronic nonspecific diarrhoea of childhood – intervention study
Query!
Scientific title
Safety and efficacy of a combination of oligofructose and inulin used for chronic nonspecific diarrhoea of childhood when compared with dietary recommendations
Query!
Secondary ID [1]
285550
0
Nil known
Query!
Universal Trial Number (UTN)
U1111-1163-3812
Query!
Trial acronym
Query!
Linked study record
Query!
Health condition
Health condition(s) or problem(s) studied:
Chronic nonspecific diarrhoea of childhood
293368
0
Query!
Condition category
Condition code
Oral and Gastrointestinal
293651
293651
0
0
Query!
Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colon
Query!
Intervention/exposure
Study type
Interventional
Query!
Description of intervention(s) / exposure
Name of intervention: oral supplement of 4 g of inulin enriched with oligofructose (1/1, 2g oligofructose and 2g inulin per day), 1 sachet/day, for 3 months consecutively
Strategy used to monitor adherence to the intervention: sachets return
Query!
Intervention code [1]
290495
0
Treatment: Other
Query!
Intervention code [2]
291722
0
Treatment: Devices
Query!
Comparator / control treatment
Dietary recommendation administrated during the enrollment visit lasting for 45 minutes of face-to-face discussion with pediatrician and parents that could ask questions about the diet: Fruit juice intake minimized, juice with low sucrose and fructose loads; normal caloric intake; not to restrict fiber, and to assure adequate but not overhydration (150ml/kg/d)
Query!
Control group
Active
Query!
Outcomes
Primary outcome [1]
293464
0
Primary Outcome 1: duration of acute episodes in chronic nonspecific diarrhoea
acute episode: defined as increased stool frequency with changes of stool consistency appreciated according to the Bristol Stool Form Scale, where 1 represents hard stools, 7 indicates watery stools, scores lower than 5 indicate normal stool
duration of acute episodes: is defined as the time from the first loose stool, until at least 12 hours without stool.
Query!
Assessment method [1]
293464
0
Query!
Timepoint [1]
293464
0
Timepoint: during intervention and 3 months after intervention stopped
Query!
Primary outcome [2]
293465
0
Primary Outcome 2: severity of acute episode in chronic nonspecific diarrhoea evaluated by association of symptoms: vomiting, abdominal pain, constipation; this was marked with Yes/No answers and counted as episodes per period between visits
Query!
Assessment method [2]
293465
0
Query!
Timepoint [2]
293465
0
Timepoint: during intervention and 3 months after intervention stoped
Query!
Secondary outcome [1]
311103
0
Need for antibiotic use for acute infectious intestinal episodes
Query!
Assessment method [1]
311103
0
Query!
Timepoint [1]
311103
0
Timepoint: during intervention and 3months after intervention stoped
Query!
Secondary outcome [2]
311640
0
use of antibiotics for any reasons, acute infections during the follow up procedure; the first one refers to intestinal infections and the second one refers to use of antibiotics in general
Query!
Assessment method [2]
311640
0
Query!
Timepoint [2]
311640
0
during intervention and 3 months after intervention stoped
Query!
Secondary outcome [3]
311641
0
safety and efficiency of the supplement appreciated by a questionnaire completed by parents in terms of treatment efficiency and acceptance (very good/ good/ moderate were the answers options).
Query!
Assessment method [3]
311641
0
Query!
Timepoint [3]
311641
0
during intervention and 3 months after intervention stoped
Query!
Secondary outcome [4]
314329
0
hospitalization : yes/no answers, duration of hospitalization in days
Query!
Assessment method [4]
314329
0
Query!
Timepoint [4]
314329
0
during the follow up procedure
Query!
Eligibility
Key inclusion criteria
(1) age 1 to 5 years
(2) at least 5 episodes of diarrhoea in the last 6 months
(3) normal weight and length for age
(4) normal development
Query!
Minimum age
1
Years
Query!
Query!
Maximum age
5
Years
Query!
Query!
Sex
Both males and females
Query!
Can healthy volunteers participate?
No
Query!
Key exclusion criteria
comorbidities of any kind
abnormal nutritional status
acute infections
food allergies
coeliac disease
inflammatory bowel disease
gastrointestinal malformation
Query!
Study design
Purpose of the study
Treatment
Query!
Allocation to intervention
Non-randomised trial
Query!
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Query!
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Query!
Masking / blinding
Open (masking not used)
Query!
Who is / are masked / blinded?
Query!
Query!
Query!
Query!
Intervention assignment
Parallel
Query!
Other design features
Query!
Phase
Not Applicable
Query!
Type of endpoint/s
Safety/efficacy
Query!
Statistical methods / analysis
Statistical analysis was performed using linear regression, and p values of < 0.05 were considered statistically significant. The descriptive results were emphasized using means (+/-SD) or medians and interquantile ranges. Comparative results were obtained with T-test and Mann-Whitney U-tests. Data were summarize for demographic characteristics , efficacy observation and safety observation using standard deviation statistics. We choose to enroll all patients that had the inclusion criteria through clinical assumption, as a pilot study. Sample size was calculated assuming a proportion of 0.7, with 0.05 precision and a confidence level of 80%.
Query!
Recruitment
Recruitment status
Completed
Query!
Date of first participant enrolment
Anticipated
7/11/2012
Query!
Actual
7/11/2012
Query!
Date of last participant enrolment
Anticipated
22/02/2013
Query!
Actual
22/02/2013
Query!
Date of last data collection
Anticipated
Query!
Actual
Query!
Sample size
Target
54
Query!
Accrual to date
Query!
Final
Query!
Recruitment outside Australia
Country [1]
6438
0
Romania
Query!
State/province [1]
6438
0
Bucharest
Query!
Funding & Sponsors
Funding source category [1]
290153
0
Hospital
Query!
Name [1]
290153
0
"Grigore Alexandrescu” Children Emergency Hospital
Query!
Address [1]
290153
0
30-32 Iancu de Hunedoara Boulevard, zip code 11743, Bucharest
Query!
Country [1]
290153
0
Romania
Query!
Primary sponsor type
Hospital
Query!
Name
"Grigore Alexandrescu” Children Emergency Hospital
Query!
Address
30-32 Iancu de Hunedoara Boulevard, zip code 11743, Bucharest
Query!
Country
Romania
Query!
Secondary sponsor category [1]
288863
0
None
Query!
Name [1]
288863
0
Query!
Address [1]
288863
0
Query!
Country [1]
288863
0
Query!
Ethics approval
Ethics application status
Approved
Query!
Ethics committee name [1]
291863
0
Ethics Committee of : "Grigore Alexandrescu” Children Emergency Hospital
Query!
Ethics committee address [1]
291863
0
30-32 Iancu de Hunedoara Boulevard, zip code 11743, Bucharest
Query!
Ethics committee country [1]
291863
0
Romania
Query!
Date submitted for ethics approval [1]
291863
0
Query!
Approval date [1]
291863
0
21/09/2012
Query!
Ethics approval number [1]
291863
0
12724
Query!
Summary
Brief summary
We included patients aged 1 to 5 years old, with at least 5 episodes of diarrhea in the last 6 months fulfilling the criteria of chronic nonspecific diarrhea. The first 31 patients represented the interventional group, named Group A, and the next 23 patients were in the control group (marked as Group B). Group A received a combination of oligofructose and inulin, 4 g/day, divided in 2 daily oral doses for a period of 3 months, and Group B received only dietary recommendations, according to the current guideline. The follow up evaluation included 6 medical visits, the first visit was at the time of inclusion, the second was after 2 weeks, the 3rd visit was after another 2 weeks, the 4th and 5th visits were performed every 30 days and the 6th visit took place after 3 months. The first end point was obtained by comparing clinical efficiency evaluated using gastrointestinal symptoms (vomiting, abdominal pain, constipation) marked with Yes/No answers and counted as episodes per period between visits, number of acute episodes (defined as increased stool frequency with changes of stool consistency) appreciated according to the Bristol Stool Form Scale, where 1 represents hard stools, 7 indicates watery stools, scores lower than 5 indicate normal stool, and the duration of acute episodes is defined as the time from the first loose stool, until at least 12 hours without stool. The second end point consisted of hospitalization (Yes/No answers and the duration of hospitalization according to medical files), use of antibiotics (Yes/No answers were registered), safety and efficiency appreciated by a questionnaire completed by parents in terms of treatment efficiency and acceptance (very good/ good/ moderate were the answers options).
Query!
Trial website
Query!
Trial related presentations / publications
1. 47th Annual Meeting of The European Society for Pediatric Gastroenterology, Hepatology and Nutrition 9 - 12 June 2014 Jerusalem, Israel; Chronic nonspecific diarrhea of childhood : Does oligofructose and inuline combination really work? Cristina Becheanu, Iulia Tincu, Roxana Smadeanu, Ana Maria Bradeanu, Gabriela Lesanu; poster presentation; abstract published in JPGN, Volume 58, Supplement 1, June 2014. 2. 2nd International Symposium of Probiotics and Prebiotics in Pediatrics March 7-9, 2014, Antalya,Turkey; Does combination of oligofructose and inuline reduce the severity of chronic nonspecific diarrhea of childhood? Becheanu Cristina, Lesanu Gabriela, Smadeanu Roxana, Tincu Iulia; oral presentation.
Query!
Public notes
Query!
Contacts
Principal investigator
Name
52326
0
Dr Becheanu Cristina Adriana
Query!
Address
52326
0
"Grigore Alexandrescu” Children Emergency Hospital, 30-32 Iancu de Hunedoara Boulevard, zip code 11743, Bucharest
Query!
Country
52326
0
Romania
Query!
Phone
52326
0
+40213169366
Query!
Fax
52326
0
+40213127938
Query!
Email
52326
0
[email protected]
Query!
Contact person for public queries
Name
52327
0
Tincu Iulia Florentina
Query!
Address
52327
0
"Grigore Alexandrescu” Children Emergency Hospital, 30-32 Iancu de Hunedoara Boulevard, zip code 11743, Bucharest
Query!
Country
52327
0
Romania
Query!
Phone
52327
0
+40725535100
Query!
Fax
52327
0
+40213127938
Query!
Email
52327
0
[email protected]
Query!
Contact person for scientific queries
Name
52328
0
Becheanu Cristina Adriana
Query!
Address
52328
0
"Grigore Alexandrescu” Children Emergency Hospital, 30-32 Iancu de Hunedoara Boulevard, zip code 11743, Bucharest
Query!
Country
52328
0
Romania
Query!
Phone
52328
0
+40213169366
Query!
Fax
52328
0
+40213127938
Query!
Email
52328
0
[email protected]
Query!
No information has been provided regarding IPD availability
What supporting documents are/will be available?
No Supporting Document Provided
Results publications and other study-related documents
Documents added manually
No documents have been uploaded by study researchers.
Documents added automatically
No additional documents have been identified.
Download to PDF